The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Open accessAbstract
Nanotechnology offers many advantages in various fields of science. In this regard, nanoparticles are the essential building blocks of nanotechnology. Recent advances in nanotechnology have proven that nanoparticles acquire a great potential in medical applications. Formation of stable interactions with ligands, variability in size and shape, high carrier capacity, and convenience of binding of both hydrophilic and hydrophobic substances make nanoparticles favorable platforms for the target-specific and controlled delivery of micro- and macromolecules in disease therapy. Nanoparticles combined with the therapeutic agents overcome problems associated with conventional therapy; however, some issues like side effects and toxicity are still debated and should be well concerned before their utilization in biological systems. It is therefore important to understand the specific properties of therapeutic nanoparticles and their delivery strategies. Here, we provide an overview on the unique features of nanoparticles in the biological systems. We emphasize on the type of clinically used nanoparticles and their specificity for therapeutic applications, as well as on their current delivery strategies for specific diseases such as cancer, infectious, autoimmune, cardiovascular, neurodegenerative, ocular, and pulmonary diseases. Understanding of the characteristics of nanoparticles and their interactions with the biological environment will enable us to establish novel strategies for the treatment, prevention, and diagnosis in many diseases, particularly untreatable ones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Lipid Nanocarriers (LNC) and their Applications in Ocular Drug Delivery
Puglia, C., Offerta, A., Carbone, C., Bonina, F. P., Pignatello, R., & Puglisi, G. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209152259 · Cited by 64
Nanobiomaterials’ applications in neurodegenerative diseases
Silva‐Adaya, D., Aguirre‐Cruz, L., Guevara, J., & Ortiz-Islas, E. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216659032 · Cited by 62
Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy
Li, T. X., Lu, L., Qiao, Y., Ravi, S., Salatan, F., & Melancon, M. P. (2016) · Journal of Functional Biomaterials · doi:10.3390/jfb7030019 · Cited by 62
Chakraborti, S., Mandal, A. K., Sarwar, S., Singh, P., Chakraborty, R., & Chakrabarti, P. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.044 · Cited by 59
Zhou, J., Li, M., Lim, W. Q., Luo, Z. Y., Phua, S. Z. F., Huo, R., Li, L., Li, K., Dai, L., Liu, J., et al. (2017) · Theranostics · doi:10.7150/thno.21194 · Cited by 59
Certolizumab pegol for the treatment of rheumatoid arthritis
Horton, S., Walsh, C. A., & Emery, P. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.645533 · Cited by 58
Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria
Wang, L., Chen, Y. P., Miller, K. P., Cash, B. M., Jones, S. R., Glenn, S., Benicewicz, B. C., & Decho, A. W. (2014) · Chemical Communications · doi:10.1039/c4cc04936e · Cited by 58
Mazibuko, Z., Choonara, Y. E., Kumar, P., du Toit, L. C., Modi, G., Naidoo, D., & Pillay, V. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24322 · Cited by 56
Madamsetty, V. S., Pal, K., Keshavan, S., Caulfield, T. R., Dutta, S. K., Wang, E., Fadeel, B., & Mukhopadhyay, D. (2019) · Nanoscale · doi:10.1039/c9nr05478b · Cited by 56
Crotty, S., Fitzgerald, P., Tuohy, E., Harris, D., Fisher, A., Mandel, A., Bolton, A. E., Sullivan, A. M., & Nolan, Y. M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.06018.x · Cited by 55
Shaik, N., Pan, G., & Elmquist, W. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21372 · Cited by 55
Polymeric Nanoparticles for Enhancing Antiretroviral Drug Therapy
Govender, T., Ojewole, E. B., Naidoo, P., & Mackraj, I. (2008) · Drug Delivery · doi:10.1080/10717540802321776 · Cited by 55
DENDRIMER APPLICATIONS – A REVIEW
Patel, H. (2013) · International Journal of Pharma and Bio Sciences · Cited by 55
Pei, Y., Li, M., Hou, Y., Hu, Y., Chu, G., Dai, L., Li, K., Xing, Y., Tao, B., Yu, Y., et al. (2018) · Nanoscale · doi:10.1039/c8nr02358a · Cited by 55
Chandrasekhar, S., Iyer, L. K., Panchal, J. P., Topp, E. M., Cannon, J. B., & Ranade, V. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.797405 · Cited by 54
Ling, C., Wu, L. H., Liu, F., Qi, X., Ge, Y., & Shen, S. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02704g · Cited by 53
de Castro, S., & Camarasa, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.007 · Cited by 52
Bell, C., Anderson, J., Ganguly, T. C., Prescott, J., Capila, I., Lansing, J. C., Sachleben, R. A., Iyer, M., Fier, I., Roach, J. M., et al. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017725984 · Cited by 50
Gonçalves, R. M., Pereira, A. C. L., Pereira, I., Oliveira, M. J., & Barbosa, M. A. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5496-1 · Cited by 49
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication
Herskovitz, J., & Gendelman, H. E. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9785-6 · Cited by 49
Applications of Nanodiamonds in the Detection and Therapy of Infectious Diseases
Torres-Sangiao, E., Holban, A. M., & Gestal, M. C. (2019) · Materials · doi:10.3390/ma12101639 · Cited by 47
The effects of engineered nanoparticles on pulmonary immune homeostasis
Mohamud, R., Xiang, S. D., Selomulya, C., Rolland, J. M., O’Hehir, R. E., Hardy, C. L., & Plebanski, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.859688 · Cited by 46
Pandey, B. N., Shetake, N. G., Balla, M. M. S., & Kumar, A. (2016) · Journal of Radiation and Cancer Research · doi:10.4103/0973-0168.184606 · Cited by 44
Madamsetty, V. S., Sharma, A. K., Toma, M. A., Samaniego, S., Gallud, A., Wang, E., Pal, K., Mukhopadhyay, D., & Fadeel, B. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.02.020 · Cited by 43
Nanodiamonds as Platforms for Biology and Medicine
Man, H., & Ho, D. (2013) · SLAS TECHNOLOGY · doi:10.1177/2211068212456198 · Cited by 41
Fan, J., Wang, S., Zhang, X., et al. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00824 · Cited by 40
Löbenberg, R., Maas, J., & Kreuter, J. (1998) · Journal of drug targeting · doi:10.3109/10611869808995872 · Cited by 36
Shao, D., Li, J., Guan, F., Pan, Y., Xiao, X., Zhang, M., Zhang, H., & Chen, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73185 · Cited by 36
Exosome Research and Co-culture Study
Shimasaki, T., Yamamoto, S., & Arisawa, T. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00223 · Cited by 36
Venkatakrishnan, K., Liu, Y., Noe, D. A., Mertz, J., Bargfrede, M., Marbury, T. C., Farbakhsh, K., Oliva, C., & Milton, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12260 · Cited by 35
Park, J. S., Yi, S. W., Kim, H. J., Kim, S. M., & Park, K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08343 · Cited by 29
Choi, J., Park, Y., Choi, E. B., Kim, H., Kim, D. J., Hong, Y., Ryu, S. H., Lee, J. H., Suh, J., Yang, J., et al. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.051203 · Cited by 27
Liptrott, N. J., Giardiello, M., McDonald, T. O., Rannard, S. P., & Owen, A. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0349-y · Cited by 27
Chelle, P., Yeung, C. H. T., Croteau, S. E., Lissick, J., Balasa, V., Ashburner, C., Park, Y. S., Bonanad, S., Megías‐Vericat, J. E., Nagao, A., et al. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00809-6 · Cited by 26
Sharaf, M. G., Çetinel, S., Heckler, L. V., Damji, K. F., Unsworth, L. D., & Montemagno, C. D. (2014) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000059 · Cited by 25
Nanotechnology Applications for Glaucoma
Çetinel, S., & Montemagno, C. D. (2015) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000171 · Cited by 23
Cytotoxicity studies of selected cadmium-based quantum dots on 2D vs. 3D cell cultures
Grabowska‐Jadach, I., Żuchowska, A., Olesik, M., et al. (2018) · New Journal of Chemistry · doi:10.1039/c8nj01986j · Cited by 16
蕨, 信., Tachibana, Y., Kumegawa, M., & Hakeda, Y. (2001) · Cytotechnology · doi:10.1023/a:1008159332152 · Cited by 14
Farhat, F., Kattan, J., Ibrahim, K., Bitar, N., Haddad, N., Tamraz, S., Hatoum, H. A., & Shamseddine, A. I. (2010) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(10)70478-x · Cited by 14
Novel approach for preparing nontoxic stealth microspheres for drug delivery
Angra, P., Rizvi, S. A. A., Oettinger, C. W., & D’Souza, M. J. (2011) · European Journal of Chemistry · doi:10.5155/eurjchem.2.2.125-129.394 · Cited by 11
Cited by
Drug release study of the chitosan-based nanoparticles
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2021.e08674 · Cited by 576
“The administration of NPs depends on the target location [48, 49, 50].”
BackgroundAdvances in nanomaterial-based targeted drug delivery systems
Cheng, X., Xie, Q., & Sun, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1177151 · Cited by 395
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Hetta, H. F., Ramadan, Y. N., Al-Harbi, A. I., A. Ahmed, E., Battah, B., Abd Ellah, N. H., Zanetti, S., & Donadu, M. G. (2023) · Biomedicines · doi:10.3390/biomedicines11020413 · Cited by 333
Metadata
- Authors
- Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-05-08
- Volume
- 25
- Issue
- 9
- Pages
- 2193
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3021977647
- Cited by
- 1,080
- References
- 240
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.